The estimated Net Worth of Jason Somer is at least $144 ezer dollars as of 1 June 2024. Mr Somer owns over 577 units of Inogen Inc stock worth over $58,135 and over the last 3 years he sold INGN stock worth over $85,600.
Mr has made over 10 trades of the Inogen Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 577 units of INGN stock worth $6,670 on 1 June 2024.
The largest trade he's ever made was exercising 19,276 units of Inogen Inc stock on 1 May 2024 worth over $222,831. On average, Mr trades about 3,391 units every 49 days since 2021. As of 1 June 2024 he still owns at least 5,029 units of Inogen Inc stock.
You can see the complete history of Mr Somer stock trades at the bottom of the page.
Jason Somer is the Exec. VP, Gen. Counsel & Corp. Sec. at Inogen Inc.
Mr Somer is 53, he's been the Exec. VP és Gen. Counsel & Corp. Sec. of Inogen Inc since . There are 9 older and 7 younger executives at Inogen Inc. The oldest executive at Inogen Inc is Benjamin Anderson-Ray, 65, who is the Independent Director.
Jason's mailing address filed with the SEC is C/O INOGEN, INC., 859 WARD DRIVE, GOLETA, CA, 93111.
Over the last 11 years, insiders at Inogen Inc have traded over $242,179,025 worth of Inogen Inc stock and bought 9,125 units worth $253,950 . The most active insiders traders include Holdings A/S Novo, Timothy Petersen és Raymond Huggenberger. On average, Inogen Inc executives and independent directors trade stock every 10 days with the average trade being worth of $321,391. The most recent stock trade was executed by Jason Somer on 1 June 2024, trading 577 units of INGN stock currently worth $6,670.
inogen’s mission to improve the quality of life of supplemental oxygen users began in 2001 when mae, a beloved grandmother, was prescribed oxygen therapy. learn more about mae’s story here: http://www.inogen.com/about-inogen/meet-mae/. inogen was founded based on our conviction that oxygen therapy technology was not keeping pace with the desired lifestyles of patients who depended on it to live longer, more fulfilling lives. we estimate that more than 2.5 million patients in the united states and more than 4.5 million patients worldwide use oxygen therapy. our compact, lightweight and travel-approved portable oxygen concentrators are designed to free patients from heavy tanks, managing tank refills or being tethered to stationary systems. we believe our products allow oxygen therapy patients to reclaim their freedom and independence so that life can be lived in moments, not in minutes left in an oxygen tank. with each step we take to improve our products and service, our customers take
Inogen Inc executives and other stock owners filed with the SEC include: